Skip to main content

Table 1 Characteristics of cystic fibrosis study population receiving tobramycin inhalation solution, N = 804.

From: Adherence with tobramycin inhaled solution and health care utilization

Demographic characteristics

%*

Age, years

 

   <6**

13.2

   6-10

12.2

   11-17

31.5

   18-25

22.0

   ≥26

21.1

Gender

 

   Male

52.7

   Female

47.3

Comorbidity score

 

   ≤Average

65.3

   >Average

34.7

Geographic region

 

   Northeast

12.3

   Midwest

27.0

   South

39.1

   West

21.4

Health Plan Type

 

   Comprehensive

7.6

   HMO

23.0

   Preferred Provider Organization

49.0

   Other Plans

20.4

Selected comorbidity

 

   Pseudomonas aeruginosa

56.1

   Failure to thrive/Growth failure

4.4

  1. *percentages may not add up to 100% due to rounding
  2. **< 6 years of age further divided; 3.9% of patients were < 2 years of age and 9.3% were 2-5 years of age.